Department of Pediatrics, Taipei City Hospital-Renai Branch, Taipei, Taiwan.
Endocr Res. 2013;38(2):85-8. doi: 10.3109/07435800.2012.714432. Epub 2012 Aug 13.
An autoimmune etiology has been suggested in up to one-third of cases of chronic idiopathic urticaria (CIU), in which it has been proposed that a subset of cases are associated with thyroid autoimmunity. The objective of our present study was to verify the prevalence of thyroid antibodies in the patients with CIU.
Sixty patients aged 12-51 years, who met criteria for CIU, and 40 aged-matched healthy controls (18 males and 22 females) were participated in this study. Serum anti-thyroid antibodies (ATAs), thyroid hormones, total immunoglobulin E (IgE), and food allergen-specific IgE antibodies were measured. The CIU group was treated with anti-H1 and anti-H2 histamines for 3 weeks.
The total ATA positive rate was 27.3% (33% males and 25% females) in the CIU group. The prevalence of anti-thyroglobulin antibodies, anti-TSH-receptor antibodies, and anti-thyroid peroxidase antibodies were 16.6%, 83.3%, and 8.3%, respectively. The thyroid hormones, T3, and T4, and the TSH were within the normal limits. The radioallergosorbent test was negative for food allergens, and only 18% of the patients had a total IgE concentration >200 IU/mL.
ATAs were found in 27% of the patients with CIU, but these antibodies did not dysregulate thyroid hormone secretion nor did they mediate any clinical manifestations.
据报道,在多达三分之一的慢性特发性荨麻疹(CIU)患者中存在自身免疫病因,其中一部分病例与甲状腺自身免疫有关。本研究的目的是验证 CIU 患者甲状腺抗体的患病率。
本研究纳入了 60 名年龄在 12-51 岁之间符合 CIU 标准的患者和 40 名年龄匹配的健康对照者(18 名男性和 22 名女性)。检测了血清抗甲状腺抗体(ATAs)、甲状腺激素、总免疫球蛋白 E(IgE)和食物过敏原特异性 IgE 抗体。CIU 组接受 H1 和 H2 组胺拮抗剂治疗 3 周。
CIU 组的总 ATA 阳性率为 27.3%(男性为 33%,女性为 25%)。抗甲状腺球蛋白抗体、抗 TSH 受体抗体和抗甲状腺过氧化物酶抗体的患病率分别为 16.6%、83.3%和 8.3%。甲状腺激素 T3、T4 和 TSH 均在正常范围内。食物过敏原放射变应原吸附试验为阴性,仅 18%的患者总 IgE 浓度>200 IU/mL。
在 27%的 CIU 患者中发现了 ATAs,但这些抗体并未导致甲状腺激素分泌失调,也未介导任何临床表现。